GRP
LXRX icon

Global Retirement Partners’s Lexicon Pharmaceuticals LXRX Stock Holding History

Global Retirement Partners’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4K Buy
+1,000
New +$1.95K ﹤0.01% 3943
2025
Q4 		$1.15K Hold
1,000
– – ﹤0.01% 3861
2025
Q3 		$1.35K Hold
1,000
– – ﹤0.01% 3441
2025
Q2 		$946 Buy
+1,000
New +$648 ﹤0.01% 3457
2024
Q4 		$739 Hold
1,000
– – ﹤0.01% 3336
2024
Q3 		$1.57K Hold
1,000
– – ﹤0.01% 3009
2024
Q2 		$1.68K Hold
1,000
– – ﹤0.01% 3033
2024
Q1 		$2.4K Hold
1,000
– – ﹤0.01% 2678
2023
Q4 		$1.32K Hold
1,000
– – ﹤0.01% 2817
2023
Q3 		$1.03K Hold
1,000
– – ﹤0.01% 2763
2023
Q2 		$2.29K Hold
1,000
– – ﹤0.01% 2499
2023
Q1 		$2.74K Buy
+1,000
New +$2.29K ﹤0.01% 2388
2019
Q3 		– Sell
-1,703
Closed -$11K – 1653
2019
Q2 		$11K Buy
1,703
+259
+18% +$1.55K ﹤0.01% 1081
2019
Q1 		$8K Buy
1,444
+617
+75% +$3.75K ﹤0.01% 1113
2018
Q4 		$5K Buy
827
+635
+331% +$5.14K ﹤0.01% 1167
2018
Q3 		$2K Hold
192
– – ﹤0.01% 1401
2018
Q2 		$2K Hold
192
– – ﹤0.01% 1391
2018
Q1 		$2K Hold
192
– – ﹤0.01% 1346
2017
Q4 		$2K Buy
+192
New +$2K ﹤0.01% 1316

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Global Retirement Partners's LXRX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Lexicon Pharmaceuticals (LXRX) in Q2 2026: 1,000 shares worth $2.4K. The stake represents ﹤0.01% of the portfolio and ranks #3943 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in LXRX as recently as Q4 2025.

Global Retirement Partners first reported a position in LXRX in Q4 2017 and has held it in 19 quarters since. The position peaked at $11K in Q2 2019. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Global Retirement Partners held 1,000 shares of Lexicon Pharmaceuticals worth $2.4K as of Q2 2026.
  • Lexicon Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3943 holding.
  • Global Retirement Partners first reported a position in Lexicon Pharmaceuticals in Q4 2017 and has held it in 19 quarters since.
  • Global Retirement Partners's Lexicon Pharmaceuticals position peaked at $11K in Q2 2019.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.